title: Progressive supranuclear palsy.
abstract: Progressive supranuclear palsy (PSP) is the second-most-common parkinsonian neurodegenerative disorder following Parkinson's disease. Although PSP was first identified clinically more than 40 years ago, it remains poorly recognized and underdiagnosed. Using an individual example, this article describes the epidemiology, neuropathology, clinical course, supportive management strategies, and resources for patients with PSP and their families.
authors.affiliation: University of California, Los Angeles, CA, USA. anlom@sbcglobal.net
authors.forename: Loretta
authors.initials: L
authors.lastname: Mazorra
authors.forename: Mary P
authors.initials: MP
authors.lastname: Cadogan
mesh_terms: D000368:Aged; D006801:Humans; D008297:Male; D013494:Supranuclear Palsy, Progressive / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology*